Insider Transactions

Date Name Title Type Shares Traded Price Range
Sep 12, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 14,000 $13.53
Sep 12, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 14,000 --
Sep 12, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 25,000 --
Sep 12, 2017 Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 19,776 $18.09
Sep 12, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 25,000 $14.31
Sep 12, 2017 Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 10,471 $18.09
Aug 06, 2017 SVP, GM - Oncology Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 502 $16.56
Aug 06, 2017 SVP and General Counsel Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 495 $16.56
Jul 26, 2017 Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,976 --
Jul 26, 2017 SVP/GM, Vascular Access Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,684 --
 For recent transactions, including derivative transactions, see our Section 16 SEC filings page.